Eiger BioPharmaceuticals Announces Peginterferon Lambda to be Added to Multi-Center Phase 3 TOGETHER COVID-19 Study in Brazil

Authors
Category Primary study
Web pagePress release - PR Newswire - May 03, 2021, 08:00 ET
Year 2021
This article has no abstract
Epistemonikos ID: 3d854d4e94d1b15bb2a872a27f93fa24fe1e5b40
First added on: Jul 28, 2021